Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Buy
2,151
+95
+5% +$14.4K 0.01% 699
2026
Q1
$297K Sell
2,056
-1,767
-46% -$281K 0.01% 619
2025
Q4
$625K Buy
3,823
+837
+28% +$137K 0.01% 478
2025
Q3
$464K Sell
2,986
-2,469
-45% -$381K 0.01% 521
2025
Q2
$834K Buy
5,455
+1,419
+35% +$203K 0.02% 332
2025
Q1
$593K Buy
4,036
+1,377
+52% +$202K 0.02% 396
2024
Q4
$343K Buy
2,659
+146
+6% +$19.1K 0.01% 460
2024
Q3
$343K Buy
2,513
+445
+22% +$54.5K 0.01% 458
2024
Q2
$211K Sell
2,068
-372
-15% -$36.3K 0.01% 490
2024
Q1
$216K Sell
2,440
-338
-12% -$28K 0.01% 487
2023
Q4
$254K Buy
+2,778
New +$223K 0.01% 471
2023
Q3
Sell
-2,626
Closed -$220K 512
2023
Q2
$220K Buy
2,626
+117
+5% +$9.94K 0.01% 479
2023
Q1
$220K Buy
+2,509
New +$237K 0.01% 466
2022
Q2
Sell
-1,674
Closed -$208K 440
2022
Q1
$208K Sell
1,674
-5,266
-76% -$700K 0.01% 393
2021
Q4
$1.03M Buy
+6,940
New +$1.03M 0.06% 220

Other funds holding MMM

NorthCrest Asset Manangement's MMM Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its 3M (MMM) stake by 4.6% in Q2 2026, buying an estimated $14.4K and bringing the position to 2,151 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #699.

NorthCrest Asset Manangement first reported a position in MMM in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.03M in Q4 2021. 1,028 funds tracked by Wall St. Rank hold MMM as of Q2 2026.

  • NorthCrest Asset Manangement held 2,151 shares of 3M worth $334K as of Q2 2026.
  • NorthCrest Asset Manangement bought 95 3M shares in Q2 2026, an estimated $14.4K.
  • 3M made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #699 holding.
  • NorthCrest Asset Manangement first reported a position in 3M in Q4 2021 and has held it in 15 quarters since.
  • NorthCrest Asset Manangement's 3M position peaked at $1.03M in Q4 2021.
  • 1,028 funds tracked by Wall St. Rank held 3M as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.